SMAD2 and metabolic dysfunction-associated steatohepatitis: As shown in Fig. 3D, SMAD2, SMAD3 and c-MYC are core targets in HSCs mecciRNA-miRNA network, which have been reported to play vital roles in NASH progression [43–46].